To close this knowledge gap, there is a need for more thorough experimental research, such as case-control studies and randomized controlled trials that explicitly look at the risk of hypoglycemia associated with various GLP-1 receptor agonists in nondiabetic people during Ramadan. The gene discussed is GLP1R; the disease is Hypoglycemia.